TP53 and colorectal carcinoma: Conversely, in a retrospective analysis of relapsed stage II CRC patients, FBXW7 mutations occurred only in KRAS wild-type tumors, and co-mutations of TP53 and FBXW7 were associated with significantly shorter disease-free survival (DFS) and overall survival (OS) [80].